See more : SymBio Pharmaceuticals Limited (SYMQY) Income Statement Analysis – Financial Results
Complete financial analysis of QuiaPEG Pharmaceuticals Holding AB (publ) (QUIA.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of QuiaPEG Pharmaceuticals Holding AB (publ), a leading company in the Biotechnology industry within the Healthcare sector.
- Lucas Bols N.V. (BOLS.AS) Income Statement Analysis – Financial Results
- MS&AD Insurance Group Holdings, Inc. (MSADY) Income Statement Analysis – Financial Results
- Vista Outdoor Inc. (VSTO) Income Statement Analysis – Financial Results
- Duke Offshore Limited (DUKEOFS.BO) Income Statement Analysis – Financial Results
- Mirage Energy Corporation (MRGE) Income Statement Analysis – Financial Results
QuiaPEG Pharmaceuticals Holding AB (publ) (QUIA.ST)
About QuiaPEG Pharmaceuticals Holding AB (publ)
QuiaPEG Pharmaceuticals Holding AB (publ), a biotech company, develops biopharmaceutical products for the treatment of metabolic disorders. It develops biopharmaceuticals based on PEGylation technology platform, which is applicable on proteins, peptides, and small molecules or oligonucleotides. The company has strategic collaboration with Cobra Biologics AB for the refinement of biopharmaceutical products. The company was formerly known as Oligovation AB and changed its name to QuiaPEG Pharmaceuticals Holding AB (publ). QuiaPEG Pharmaceuticals Holding AB (publ) was founded in 2012 and is headquartered in Solna, Sweden.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.37M | 5.57M | 216.00K | 1.86M | 4.47M | 3.38M | 3.93M | 916.00K | 14.40M | 9.27M | 13.06M | 9.70M | 12.70M | 9.68M | 10.23M | 9.17M |
Cost of Revenue | 2.20M | -3.33M | -311.00K | 4.85M | -2.41M | -2.60M | -3.72M | 415.00K | 5.34M | 2.62M | 5.73M | 2.57M | 2.43M | 963.00K | 1.33M | 1.07M |
Gross Profit | 2.17M | 8.91M | 527.00K | -2.99M | 6.88M | 5.97M | 7.65M | 501.00K | 9.07M | 6.65M | 7.32M | 7.13M | 10.27M | 8.72M | 8.90M | 8.10M |
Gross Profit Ratio | 49.63% | 159.81% | 243.98% | -160.56% | 153.96% | 176.87% | 194.61% | 54.69% | 62.95% | 71.72% | 56.09% | 73.51% | 80.87% | 90.05% | 87.02% | 88.33% |
Research & Development | 3.98M | 2.24M | 640.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 9.12M | 9.63M | 13.51M | 13.77M | 8.54M | 4.92M | 1.74M | 3.81M | 3.41M | 4.21M | 5.08M | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.42M | 2.31M | 2.70M |
SG&A | 13.82M | 9.12M | 9.63M | 13.51M | 13.77M | 8.54M | 4.92M | 1.74M | 3.81M | 3.41M | 4.21M | 5.08M | 0.00 | 2.42M | 2.31M | 2.70M |
Other Expenses | 0.00 | 10.01M | 8.25M | 8.44M | 6.69M | 5.56M | 2.68M | -279.00K | 4.38M | 4.25M | 4.57M | 4.82M | 9.68M | 5.12M | 5.42M | 5.13M |
Operating Expenses | 17.68M | 19.13M | 17.88M | 21.95M | 20.46M | 14.10M | 7.60M | 1.46M | 8.19M | 7.66M | 8.78M | 9.90M | 9.68M | 7.54M | 7.73M | 7.83M |
Cost & Expenses | 19.89M | 15.79M | 17.57M | 26.79M | 18.05M | 11.50M | 3.88M | 1.88M | 13.52M | 10.28M | 14.51M | 12.47M | 12.11M | 8.50M | 9.06M | 8.90M |
Interest Income | 2.00K | 4.30M | 2.43M | 2.78M | 1.53M | 0.00 | 0.00 | 387.00K | 4.00K | 450.00K | 31.00K | 90.00K | 202.00K | 38.00K | 56.00K | 86.00K |
Interest Expense | 1.01M | 4.30M | 2.43M | 2.78M | 1.53M | 550.00K | 590.00K | 0.00 | 49.00K | 75.00K | 41.00K | 142.00K | 109.00K | 834.00K | 468.00K | 87.00K |
Depreciation & Amortization | 2.08M | 1.82M | 1.56M | 1.27M | 861.00K | 305.00K | 3.88M | 2.16M | 785.00K | 904.00K | 814.00K | 992.00K | 2.29M | 1.14M | 1.37M | 926.00K |
EBITDA | -13.43M | -13.98M | -16.01M | -23.67M | -17.19M | -11.20M | 0.00 | 9.60M | 441.00K | 298.00K | -607.00K | -1.89M | 2.98M | 1.52M | 2.17M | 1.28M |
EBITDA Ratio | -307.06% | -222.93% | -7,114.81% | -1,271.74% | -384.95% | -331.54% | -98.63% | 1,047.49% | 10.36% | 3.22% | -4.65% | -19.47% | 22.69% | 23.97% | 24.94% | 13.95% |
Operating Income | -15.51M | -15.79M | -17.57M | -24.93M | -18.05M | -11.50M | -3.88M | -961.00K | 880.00K | -1.01M | -1.45M | -2.78M | 594.00K | 1.18M | 1.17M | 267.00K |
Operating Income Ratio | -354.64% | -283.35% | -8,133.33% | -1,339.82% | -404.23% | -340.60% | -98.60% | -104.91% | 6.11% | -10.89% | -11.12% | -28.64% | 4.68% | 12.17% | 11.45% | 2.91% |
Total Other Income/Expenses | -1.01M | -4.30M | -2.43M | -2.78M | -1.53M | -550.00K | -591.00K | 10.56M | 45.00K | 328.00K | -46.00K | -244.00K | 93.00K | 329.00K | -457.00K | -1.00K |
Income Before Tax | -16.52M | -20.09M | -20.00M | -27.71M | -19.58M | -12.05M | -4.47M | 9.60M | 658.00K | -681.00K | -1.46M | -3.02M | 784.00K | 349.00K | 714.00K | 266.00K |
Income Before Tax Ratio | -377.75% | -360.41% | -9,259.26% | -1,488.98% | -438.42% | -356.88% | -113.63% | 1,047.49% | 4.57% | -7.35% | -11.20% | -31.17% | 6.17% | 3.61% | 6.98% | 2.90% |
Income Tax Expense | 0.00 | 4.30M | 2.43M | 2.78M | 1.53M | 144.86K | -3.88M | 8.40M | 80.00K | -7.00K | 210.00K | 64.00K | 408.00K | 275.00K | 666.00K | -487.00K |
Net Income | -16.52M | -24.38M | -22.43M | -30.49M | -21.11M | -12.05M | -4.47M | 9.60M | 578.00K | -674.00K | -1.67M | -3.09M | 376.00K | 74.00K | 48.00K | 753.00K |
Net Income Ratio | -377.75% | -437.46% | -10,384.72% | -1,638.15% | -472.62% | -356.88% | -113.63% | 1,047.49% | 4.01% | -7.27% | -12.81% | -31.82% | 2.96% | 0.76% | 0.47% | 8.21% |
EPS | -0.22 | -6.80 | -17.69 | -47.11 | -29.72 | -20.44 | -9.24 | 170.01 | 5.22 | -13.83 | -34.31 | -63.31 | 7.83 | -22.18 | 0.02 | 17.39 |
EPS Diluted | -0.22 | -6.80 | -17.69 | -47.11 | -29.72 | -20.44 | -9.24 | 170.01 | 5.22 | -10.23 | -34.31 | -63.31 | 7.83 | -22.18 | 0.01 | 17.39 |
Weighted Avg Shares Out | 74.50M | 3.59M | 1.27M | 647.07K | 710.10K | 589.70K | 483.41K | 56.39K | 48.73K | 48.73K | 48.73K | 48.73K | 48.73K | 48.73K | 48.73K | 48.25K |
Weighted Avg Shares Out (Dil) | 74.50M | 3.59M | 1.27M | 647.07K | 710.10K | 589.70K | 483.41K | 56.39K | 48.73K | 65.91K | 48.73K | 48.73K | 48.73K | 48.73K | 48.73K | 63.04K |
Source: https://incomestatements.info
Category: Stock Reports